| Literature DB >> 29632194 |
Qibiao Wu1, Yahui Tian2, Jian Zhang1, Xinyuan Tong1, Hsinyi Huang1, Shuai Li3, Hong Zhao2, Ying Tang1, Chongze Yuan4,5, Kun Wang6, Zhaoyuan Fang1, Lei Gao2, Xin Hu7,8, Fuming Li1, Zhen Qin1, Shun Yao1, Ting Chen3, Haiquan Chen4,5, Gong Zhang2, Wanting Liu2, Yihua Sun4,5, Luonan Chen1, Kwok-Kin Wong3, Kai Ge9, Liang Chen10, Hongbin Ji11,12.
Abstract
Lung cancer is the leading cause of cancer-related death worldwide. Inactivation of tumor suppressor genes (TSGs) promotes lung cancer malignant progression. Here, we take advantage of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated somatic gene knockout in a KrasG12D/+ mouse model to identify bona fide TSGs. From individual knockout of 55 potential TSGs, we identify five genes, including Utx, Ptip, Acp5, Acacb, and Clu, whose knockout significantly promotes lung tumorigenesis. These candidate genes are frequently down-regulated in human lung cancer specimens and significantly associated with survival in patients with lung cancer. Through crossing the conditional Utx knockout allele to the KrasG12D/+ mouse model, we further find that Utx deletion dramatically promotes lung cancer progression. The tumor-promotive effect of Utx knockout in vivo is mainly mediated through an increase of the EZH2 level, which up-regulates the H3K27me3 level. Moreover, the Utx-knockout lung tumors are preferentially sensitive to EZH2 inhibitor treatment. Collectively, our study provides a systematic screening of TSGs in vivo and identifies UTX as an important epigenetic regulator in lung tumorigenesis.Entities:
Keywords: CRISPR/Cas9 in vivo knockout; EZH2 inhibitor; UTX; non-small cell lung cancer; tumor suppressor genes
Mesh:
Substances:
Year: 2018 PMID: 29632194 PMCID: PMC5924887 DOI: 10.1073/pnas.1716589115
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205